URMC »Research » Research@URMC Blog

Featured Blog Post Image

Telomeres Might Predict Lung Cancer Recurrence

Telomeres are sections of DNA that tell an interesting story about lifespan. Shorter telomeres usually suggest a shorter life -- but new research by a Wilmot lung cancer expert shows that longer telomeres might be a promising biomarker for a recurrence of early stage lung cancer.

Postcards from Health Care

After a memorable day in the lab or at the hospital, try writing a 55-word story to capture your inner most thoughts and experiences. This month in the journal Family Medicine, Colleen T. Fogarty, M.D., presents a collection of these cathartic writings. Like haiku (or twitter), the low word count forces the writer to connect with what’s important, and to explicitly share challenges, regrets, empathy.

10/24/2013 | 0 comments

A Good Night’s Sleep Really Does ‘Clear the Mind’

Why do we sleep?  It is a question that has long puzzled scientists and philosophers alike.  While the ancient Greeks saw sleep as a doorway to the divine, scientists and biologists see it as an invitation to be devoured by nocturnal predators.  A new study – appearing today in the journal Science – may provide the answer: when we sleep our brain ‘takes out the trash.’

10/17/2013 | 6 comments

New Concussion Data: Two Biomarkers Better Than One

Scientists are scrambling to gather data for the FDA to support the need for a blood test to diagnose brain injury in the United States. The University of Rochester Medical Center just added significant evidence by reporting in the Journal of Neurotrauma that it might be clinically useful to measure two brain biomarkers instead of one.

10/15/2013 | 0 comments

Testicular Cancer: A Good News/Bad News Story

First, the good news: The survival rate for testicular cancer is 95 percent at 10 years, due to the invention of cisplatin-based chemotherapy in the 1970s. Despite this success, however, survivors have an increasing risk of second malignancies -- and the risk remains elevated for 35 years.

10/9/2013 | 0 comments

Stomach Flu Vaccine Looks Good in Early Trial

A new vaccine for norovirus – the microbe behind most cases of what people commonly call stomach flu – protected patients against severe vomiting and diarrhea. URMC was one of five study sites that enrolled patients and tested the experimental vaccine. 

10/8/2013 | 0 comments